558 related articles for article (PubMed ID: 17409422)
1. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
2. Novel human prostate epithelial cell culture models for the study of carcinogenesis and of normal stem cells and cancer stem cells.
Rhim JS; Li H; Furusato B
Adv Exp Med Biol; 2011; 720():71-80. PubMed ID: 21901619
[TBL] [Abstract][Full Text] [Related]
3. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
Rentala S; Mangamoori LN
J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
[TBL] [Abstract][Full Text] [Related]
4. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
[TBL] [Abstract][Full Text] [Related]
5. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo.
Gu G; Yuan J; Wills M; Kasper S
Cancer Res; 2007 May; 67(10):4807-15. PubMed ID: 17510410
[TBL] [Abstract][Full Text] [Related]
7. A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
Gu Y; Kim KH; Ko D; Nakamura K; Yasunaga Y; Moul JW; Srivastava S; Arnstein P; Rhim JS
Int J Oncol; 2004 Oct; 25(4):1057-64. PubMed ID: 15375556
[TBL] [Abstract][Full Text] [Related]
8. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
[TBL] [Abstract][Full Text] [Related]
9. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
[TBL] [Abstract][Full Text] [Related]
10. Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.
Gu Y; Kim KH; Ko D; Srivastava S; Moul JW; McLeod DG; Rhim JS
Anticancer Res; 2005; 25(1A):1-8. PubMed ID: 15816512
[TBL] [Abstract][Full Text] [Related]
11. Prospective identification of tumorigenic prostate cancer stem cells.
Collins AT; Berry PA; Hyde C; Stower MJ; Maitland NJ
Cancer Res; 2005 Dec; 65(23):10946-51. PubMed ID: 16322242
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.
Kim KH; Dobi A; Shaheduzzaman S; Gao CL; Masuda K; Li H; Drukier A; Gu Y; Srikantan V; Rhim JS; Srivastava S
Prostate Cancer Prostatic Dis; 2007; 10(1):30-8. PubMed ID: 17075604
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
[TBL] [Abstract][Full Text] [Related]
14. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
15. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells.
Moriyama T; Ohuchida K; Mizumoto K; Cui L; Ikenaga N; Sato N; Tanaka M
Cancer; 2010 Jul; 116(14):3357-68. PubMed ID: 20564084
[TBL] [Abstract][Full Text] [Related]
17. Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
Goodyear SM; Amatangelo MD; Stearns ME
Prostate; 2009 May; 69(7):689-98. PubMed ID: 19143028
[TBL] [Abstract][Full Text] [Related]
18. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
[TBL] [Abstract][Full Text] [Related]
19. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
20. Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.
Cioffi M; D'Alterio C; Camerlingo R; Tirino V; Consales C; Riccio A; Ieranò C; Cecere SC; Losito NS; Greggi S; Pignata S; Pirozzi G; Scala S
Sci Rep; 2015 May; 5():10357. PubMed ID: 26020117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]